We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Avaulta Versus Anterior Repair

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00627549
Recruitment Status : Unknown
Verified February 2008 by Zealand University Hospital.
Recruitment status was:  Not yet recruiting
First Posted : March 3, 2008
Last Update Posted : March 3, 2008
Information provided by:
Zealand University Hospital

February 22, 2008
March 3, 2008
March 3, 2008
Not Provided
Not Provided
Does Avaulta Plus reduce the recurrence rate defined as a POP-Q Aa <-2 cm at follow-up after 1 yr. [ Time Frame: one year ]
Same as current
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
Avaulta Versus Anterior Repair
The Use of Avaulta Plus for Anterior Repair. A Multicenter Randomised Prospective Controlled Study


Vaginal prolapse is a well-known disease and is observed in approximately 11% of all postmenopausal women and tending to increase with age. Consequently, many surgical procedures have been developed in order to ensure sufficient support for the bladder, rectum or vaginal vault depending on the site of the defect. However, many procedures are associated with a high recurrence rate up to 40 % even within one to two years after the surgical procedure.

Due to the high recurrence rate new methods include the use of mesh, either biologically or synthetic. The latter is a permanent implant and therefore theoretically may result in a long-lasting anatomically correct position of the prolapse.

Although the recurrence rate may be lower using a mesh such surgical procedures may be associated with adverse events such as erosions of the vaginal mucosa. Others have observed shrinkage of the vaginal mucosa. However, in these studies large prolene mesh have been used. In contrast the recurrence rate is lowered up to 25%.

The above-mentioned advantage of synthetic mesh is however, mostly based on few non-randomised studies. We therefore find it of importance to evaluate whether a surgical procedure using a mesh implant is superior to conventional surgical techniques. The present study is a clinical controlled study where patients with anterior vaginal prolapse are randomised to either a mesh technique or a standard anterior procedure.

The present study includes only two more visits at the outpatient clinic after the surgical procedure. Furthermore the patients have to fulfil questionnaires regarding urinary and faecal leakage and sexual habits.

Any participation in the study is totally voluntary and the patient may at any time withdraw herself. In any case the patient will receive our standard treatment.

The study is performed in all the Scandinavian countries.

Not Provided
Not Provided
Not Provided
Vaginal Prolapse
  • Procedure: Avaulta (surgical procedure using a mesh implant)
    The use of Avaulta
  • Procedure: Conventional surgery (anterior repair)
    Anterior repair surgery
  • Active Comparator: 1
    Intervention: Procedure: Avaulta (surgical procedure using a mesh implant)
  • Active Comparator: 2
    Intervention: Procedure: Conventional surgery (anterior repair)

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
Unknown status
Not Provided
Not Provided
Not Provided

Inclusion Criteria:

  • Women aged > 55 yr
  • Women with anterior vaginal wall prolapse stage >2 according to POP-Q classification
  • Good understanding the language in word and writing

Exclusion Criteria:

  • A history of previous major pelvic surgery with the exception of a hysterectomy for reasons other than genital prolapse
  • Patients with previous vaginal surgery because of defects in the anterior of posterior compartments
  • Previous hysterectomy because of vaginal prolapse
  • Patients with prolapse of uterus or an enterocele > stage 2
  • Patients with previous TVT performed through the obturator membrane
  • History of genital or abdominal cancer
  • Patients treated with corticosteroids
  • Not able to understand the study protocol (language problems, cognitive dysfunction etc.)
Sexes Eligible for Study: Female
18 Years and older   (Adult, Senior)
Contact information is only displayed when the study is recruiting subjects
Avaulta 17431
Not Provided
Not Provided
Not Provided
Not Provided
Zealand University Hospital
Not Provided
Not Provided
Zealand University Hospital
February 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP